These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25195764)

  • 21. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.
    Lewczuk P; Riederer P; O'Bryant SE; Verbeek MM; Dubois B; Visser PJ; Jellinger KA; Engelborghs S; Ramirez A; Parnetti L; Jack CR; Teunissen CE; Hampel H; Lleó A; Jessen F; Glodzik L; de Leon MJ; Fagan AM; Molinuevo JL; Jansen WJ; Winblad B; Shaw LM; Andreasson U; Otto M; Mollenhauer B; Wiltfang J; Turner MR; Zerr I; Handels R; Thompson AG; Johansson G; Ermann N; Trojanowski JQ; Karaca I; Wagner H; Oeckl P; van Waalwijk van Doorn L; Bjerke M; Kapogiannis D; Kuiperij HB; Farotti L; Li Y; Gordon BA; Epelbaum S; Vos SJB; Klijn CJM; Van Nostrand WE; Minguillon C; Schmitz M; Gallo C; Lopez Mato A; Thibaut F; Lista S; Alcolea D; Zetterberg H; Blennow K; Kornhuber J;
    World J Biol Psychiatry; 2018 Jun; 19(4):244-328. PubMed ID: 29076399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-life dementia. Review of the APA guidelines for patient management.
    Schindler RJ; Cucio CP
    Geriatrics; 2000 Oct; 55(10):55-60; quiz 62. PubMed ID: 11054951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Gauthier S; Bodick N; Erzigkeit E; Feldman H; Geldmacher DS; Huff J; Mohs R; Orgogozo JM; Rogers S
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():6-7. PubMed ID: 9305507
    [No Abstract]   [Full Text] [Related]  

  • 24. Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Feldman H; Anand R; Blesa R; Dubois B; Gray J; Homma A; Mohr E; Morris JC; Parys W; Raschig A; Robillard A
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():61-4. PubMed ID: 9305520
    [No Abstract]   [Full Text] [Related]  

  • 25. WFSBP guidelines on how to grade treatment evidence for clinical guideline development.
    Hasan A; Bandelow B; Yatham LN; Berk M; Falkai P; Möller HJ; Kasper S;
    World J Biol Psychiatry; 2019 Jan; 20(1):2-16. PubMed ID: 30526182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological prevention of cognitive decline and dementia].
    Jessen F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 May; 63(5):506-511. PubMed ID: 32185450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.
    Bauer M; Pfennig A; Severus E; Whybrow PC; Angst J; Möller HJ;
    World J Biol Psychiatry; 2013 Jul; 14(5):334-85. PubMed ID: 23879318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological treatment strategies of residential primary care providers in dementia diseases--results of a representative survey in western Austria.
    Gurka P; Bacher R; Kemmler G; Hinterhuber H; Lingg A; Marksteiner J
    Pharmacopsychiatry; 2002 Jul; 35(4):144-9. PubMed ID: 12163984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Post SG; Beerman B; Brodaty H; Gaines AW; Gauthier SG; Geldmacher DS; Hill S; Homma A; Rossor MN; Whitehouse PJ; Winblad B
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():26-8. PubMed ID: 9305511
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Antuono P; Doody R; Gilman S; Huff J; Scheltens P; Ueda K; Khachaturian ZS
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():22-5. PubMed ID: 9305510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.
    Harvey RJ; Sciulli CG; Mason RM; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():29-32. PubMed ID: 9305512
    [No Abstract]   [Full Text] [Related]  

  • 33. Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
    van den Bussche H; Kaduszkiewicz H; Koller D; Eisele M; Steinmann S; Glaeske G; Wiese B
    Int Clin Psychopharmacol; 2011 Jul; 26(4):225-31. PubMed ID: 21394033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.
    Falkai P; Wobrock T; Lieberman J; Glenthoj B; Gattaz WF; Möller HJ;
    World J Biol Psychiatry; 2006; 7(1):5-40. PubMed ID: 16509050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comment on the S3 Guidelines Dementia by the DGPPN and the DGN from the neurological point of view].
    Wallesch CW
    Fortschr Neurol Psychiatr; 2010 Sep; 78(9):504-8. PubMed ID: 20827649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience of galantamine in dementia: a series of case reports.
    Dale MC; Libretto SE; Patterson C; Anderson J; Choudhury T; McCafferty F; McWilliam C; Richardson M
    Curr Med Res Opin; 2003; 19(6):508-18. PubMed ID: 14594523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antidementia drugs].
    Müller-Spahn F; Sollberger D; Wollmer MA
    Ther Umsch; 2009 Jun; 66(6):432-40. PubMed ID: 19496039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of paraphilias.
    Thibaut F; De La Barra F; Gordon H; Cosyns P; Bradford JM;
    World J Biol Psychiatry; 2010 Jun; 11(4):604-55. PubMed ID: 20459370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic drugs in dementia: benefits and harm.
    Ballard C; Howard R
    Nat Rev Neurosci; 2006 Jun; 7(6):492-500. PubMed ID: 16715057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Guidelines on "pharmacotherapy of neurodegenerative dementia": an update].
    Fassbender K; Frölich L
    Nervenarzt; 2014 Dec; 85(12):1589-600; quiz 1601-2. PubMed ID: 25476188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.